LEADER 01371nam--2200433---450- 001 990003210720203316 005 20100308130105.0 010 $a978-88-95-028-30-9 035 $a000321072 035 $aUSA01000321072 035 $a(ALEPH)000321072USA01 035 $a000321072 100 $a20090326d2008----km-y0itay50------ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aDisegno arte immagine$ediari pedagogici$fCarolina Carluccio, Valeria Nuzzo 210 $aSalerno$cCUES$d2008 215 $a312 p.$d24 cm 410 0$12001 454 0$12001 606 0 $aDisegno$xInsegnamento$xScuole materne [e] scuole elementari$2BNCF 676 $a372.52 700 1$aCARLUCCIO,$bCarolina$0568433 701 1$aNUZZO,$bValeria$0151401 801 0$aIT$bsalbc$gISBD 912 $a990003210720203316 951 $aII.4. 3792a$b215868 L.M.$cII.4.$d00187270 951 $aII.4. 3792$b215868 L.M.$cII.4.$d00187271 951 $aII.4. 3792b$b215455 L.M.$cII.4.$d00226698 959 $aBK 969 $aUMA 979 $aALESSANDRA$b90$c20090326$lUSA01$h1232 979 $aALESSANDRA$b90$c20090326$lUSA01$h1237 979 $aALESSANDRA$b90$c20090326$lUSA01$h1237 979 $aALESSANDRA$b90$c20100308$lUSA01$h1259 979 $aALESSANDRA$b90$c20100308$lUSA01$h1301 996 $aDisegno arte immagine$91011862 997 $aUNISA LEADER 03016nam 2200577Ia 450 001 9910452082503321 005 20200520144314.0 010 $a1-280-50667-9 010 $a9786610506675 010 $a0-309-65577-3 035 $a(CKB)1000000000465560 035 $a(EBL)3378103 035 $a(SSID)ssj0000137676 035 $a(PQKBManifestationID)11158795 035 $a(PQKBTitleCode)TC0000137676 035 $a(PQKBWorkID)10088602 035 $a(PQKB)10195975 035 $a(MiAaPQ)EBC3378103 035 $a(Au-PeEL)EBL3378103 035 $a(CaPaEBR)ebr10132071 035 $a(CaONFJC)MIL50667 035 $a(OCoLC)923275635 035 $a(EXLCZ)991000000000465560 100 $a20060809d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDeveloping a national registry of pharmacologic and biologic clinical trials$b[electronic resource] $eworkshop report /$fCommittee on Clinical Trial Registries, Board on Health Sciences Policy, Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$dc2006 215 $a1 online resource (124 p.) 300 $aDescription based upon print version of record. 311 $a0-309-10078-X 320 $aIncludes bibliographical references (p. 47-48). 327 $a""Front Matter""; ""Independent Report Reviewers ""; ""Foreword ""; ""Preface ""; ""Contents ""; ""List of Tables ""; ""1 Summary ""; ""2 The Need for Clinical Trial Registries ""; ""3 Current Registry Activities ""; ""4 Content of a Clinical Trial Registry ""; ""5 Implementation Issues ""; ""6 Conclusion and Next Steps ""; ""References ""; ""APPENDIXES""; ""A Participants and Invited Experts Between December 1, 2004, and June 27, 2005 ""; ""B Workshop Agenda, Speakers, Panelists, and Participants: June 27, 2005 "" 327 $a""C Section 113 of the Food and Drug Administration Modernization Act of 1997 and Guidance for Industry: Information Programs on Clinical Trials for Serious or Life- Threatening Diseases and Conditions. U.S. Department of Health and Human Services.""""D Published Journal Editorials ""; ""E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases""; ""F Illustrative Data Fields for the Results Summary (based on ICH E3 template) ""; ""G Biographical Sketches of Committee Members "" 606 $aClinical trials$zUnited States 606 $aClinical medicine$xResearch 608 $aElectronic books. 615 0$aClinical trials 615 0$aClinical medicine$xResearch. 676 $a615.5072 712 02$aInstitute of Medicine (U.S.).$bCommittee on Clinical Trial Registries. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910452082503321 996 $aDeveloping a national registry of pharmacologic and biologic clinical trials$92122028 997 $aUNINA